Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [04/25/2025 07:42 PDT] RMTI Expected to Trade Up After Bullish Patterns Develop
• [04/23/2025 15:33 PDT] Rockwell Medical, Inc. (NASDAQ:RMTI), Up By 100% ($0.99) From $0.99 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/10/2025 07:37 PDT] RMTI Expected to Trade Up After Bullish Patterns Develop
• [04/09/2025 07:19 PDT] RMTI Expected to Trade Up After Bullish Patterns Develop
• [04/04/2025 07:37 PDT] RMTI Expected to Trade Up After Bullish Patterns Develop
• [04/03/2025 13:58 PDT] Rockwell Medical, Inc. (NASDAQ:RMTI), Down By 100% ($1.24) From $1.24 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/31/2025 10:29 PDT] Rockwell Medical, Inc. (NASDAQ:RMTI), Down By 100% ($1.35) From $1.35 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/27/2025 07:30 PDT] RMTI Expected to Trade Down After Bearish Patterns Develop
• [03/24/2025 06:58 PDT] RMTI Expected to Trade Down After Bearish Patterns Develop
• [03/20/2025 21:16 PDT] Market Maker Surveillance Report. RMTI, Losing Stocks With Lowest Price Friction For Thursday, March 20th 2025
• [03/12/2025 15:33 PDT] RMTI SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [03/10/2025 07:52 PDT] RMTI Expected to Trade Up After Bullish Patterns Develop